STAT+: Are expensive whole-body MRI scans medically useful? A new clinical trial aims to find out
A startup selling elective whole-body scans for upward of $1,000 is launching a 10-year, 100,000…
Category: Business
House panel proposes new strategy for Medicare to cover weight loss drugs Wegovy, Zepbound
WASHINGTON — As weight loss medications have exploded in popularity, a bill to allow Medicare…
Intellia says its CRISPR-based therapy can be redosed
Want to stay on top of the science and politics driving biotech today? Sign up to get…
One firm, two conflicting takes on Alnylam’s HELIOS-B
Want to stay on top of the science and politics driving biotech today? Sign up to get…
The findings from Alnylam’s highly anticipated readout
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: The CEO of Kaiser’s new health network shares why he’s making a bet on a tiny North Carolina hospital system
Outside of North Carolina, most people probably haven’t heard of Cone Health. But the relatively…
STAT+: Kaiser adds a small North Carolina health system to its Risant Health network
Kaiser Permanente on Friday announced the next deal to build out its Risant Health network…
Can JAK inhibitors bolster checkpoint inhibitors?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Change Healthcare to begin notifying patients that cyberattack compromised their private info
Change Healthcare is beginning the process of notifying a “substantial proportion” of Americans that their…
Lilly takes more actions against unapproved versions of Mounjaro
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Novant Health calls off North Carolina hospital deal, giving a win to the FTC
Just two weeks ago, it appeared Novant Health was on the precipice of finalizing a…
STAT+: Republican lawmakers criticize FDA’s partnership with CHAI on regulating AI in medicine
Republican lawmakers are sharply criticizing the Food and Drug Administration’s relationship with a nonprofit group…
STAT+: Boston Scientific to buy vascular device maker for $1.16 billion
Boston Scientific said on Tuesday it will buy Silk Road Medical, a medical device company…
A biotech’s binary bet ends badly
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Freespira bets on slow and steady, amid spectacular digital health collapses
Many digital health companies have crashed and burned after promising investors speedy adoption and huge…
.jpg)
FDA offers new guidelines for Covid-19 vaccine
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Why a big California employer ditched Elevance for some of its health plans
The California Public Employees’ Retirement System is making a drastic change to one of its…
J.P. Morgan has officially jumped into early stage biotech investing
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Biden administration to recalculate Medicare Advantage quality ratings and bonuses
The federal government is rescoring the quality ratings of this year’s Medicare Advantage plans, which…
Walgreens executive says it is ‘doubling down’ on recruiting customers into clinical trials
LOS ANGELES – For the past two years, Walgreens has tried to leverage its nationwide…
STAT+: Telehealth startup Done’s top leadership arrested under fraud charges
The CEO and clinical president of a closely watched telehealth startup prescribing ADHD-medication Adderall online…
With Avidity and Pfizer, gene therapy enters a phase
Want to stay on top of the science and politics driving biotech today? Sign up to get…
What do Parkinson’s and obesity have in common?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Why Google and Microsoft can’t defuse U.S. health care’s ticking cybersecurity problem
Facing a worsening cybersecurity crisis in health care, the Biden administration has followed a familiar…
STAT+: Google’s Verily to offer GLP-1 drugs through Lightpath, its retooled chronic care app
For the second time in as many years, Google’s health tech spinout Verily is pivoting….
Eli Lilly’s Alzheimer’s candidate, Bob Langer’s new startup, and other biotech news you need to know
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Teladoc names insurance, finance exec as its new CEO
Virtual care company Teladoc has a new chief executive officer following the abrupt departure of…
Vanda Pharmaceuticals has another suitor
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Cigna wins case to block former executive from jumping to CVS
CVS Health viewed Amy Bricker as a potential CEO. But she won’t be going to…
Novovax will be able to supply Covid-19 vaccines this fall
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Testing begins for a new form of PrEP
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Medicare Advantage plan’s quality ratings were incorrectly calculated by government, judge rules
The federal government inappropriately lowered the 2024 Medicare Advantage star ratings of SCAN Health Plan,…
Operation Warp Speed but for rare disease
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: How a device maker inundated pain patients with unwanted batteries and surprise bills
Michelle Bean is drowning in batteries she doesn’t need. For two years, the batteries and…
5 takeaways from STAT’s look at unwanted supplies and surprise bills from device maker Zynex Medical
Sending patients heaps of medical supplies to score more money from insurers is common in…
STAT+: Becton Dickinson to buy Edwards patient monitoring unit for $4.2 billion
Becton Dickinson plans to pay $4.2 billion for Edwards Lifesciences’ critical care business, which sells…
Can AstraZeneca make good on its promise?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Elevance PBM’s president out as customers complain of prescription chaos
Paul Marchetti, the head of insurer Elevance Health’s pharmacy benefit manager, has left the company…
STAT+: HHS: Change Healthcare can make data breach notifications in lieu of hospitals
Change Healthcare can notify patients whose sensitive health information has been exposed as a result…
The surprising outperformance of a new drug against existing competitors, and other biotech updates
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Biohaven’s autoimmune drug disappoints, and other biotech news updates from the week
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Akili, maker of a video game to treat ADHD, acquired for $34 million
A month after announcing it was seeking strategic alternatives, Akili Interactive, maker of a video…
Wegovy linked to lower risk of alcohol use disorder in real-world study
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Biotech’s most interesting fundraisings from the last week
Want to stay on top of the science and politics driving biotech today? Sign up to get…
More tumult at BIO amid the company’s fourth CEO in four years
Want to stay on top of the science and politics driving biotech today? Sign up to get…
In light of H5N1 outbreak, U.S. in talks with mRNA vaccine makers on bird flu
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Cue Health, Covid-19 testing company, is shutting down
In an abrupt change of course from plans earlier in the month, at-home test maker…
STAT+: Eyeing GLP-1 opportunity, Click buys assets of Better Therapeutics
Digital therapeutics company Click Therapeutics announced Wednesday it will acquire the assets of Better Therapeutics,…
Maryland takes first steps to cap drug costs
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Lilly doubles down on radiopharma
Want to stay on top of the science and politics driving biotech today? Sign up to get…